Your browser doesn't support javascript.
loading
Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: Germline BRCA mutation carriers and wild-type BRCA pancreatic ductal adenocarcinoma.
O'Reilly, Eileen M; Lee, Jonathan W; Lowery, Maeve A; Capanu, Marinela; Stadler, Zsofia K; Moore, Malcolm J; Dhani, Neesha; Kindler, Hedy L; Estrella, Hayley; Maynard, Hannah; Golan, Talia; Segal, Amiel; Salo-Mullen, Erin E; Yu, Kenneth H; Epstein, Andrew S; Segal, Michal; Brenner, Robin; Do, Richard K; Chen, Alice P; Tang, Laura H; Kelsen, David P.
Afiliación
  • O'Reilly EM; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Lee JW; Weill Cornell Medicine, New York, New York.
  • Lowery MA; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Capanu M; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Stadler ZK; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Moore MJ; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Dhani N; Weill Cornell Medicine, New York, New York.
  • Kindler HL; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Estrella H; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Maynard H; University of Chicago Medical Center, Chicago, Illinois.
  • Golan T; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Segal A; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Salo-Mullen EE; Sheba Medical Center, Tel Hashomer, Israel.
  • Yu KH; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
  • Epstein AS; Share Zedek Medical Center, Jerusalem, Israel.
  • Segal M; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Brenner R; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Do RK; Weill Cornell Medicine, New York, New York.
  • Chen AP; Memorial Sloan Kettering Cancer Center, New York, New York.
  • Tang LH; Weill Cornell Medicine, New York, New York.
  • Kelsen DP; Memorial Sloan Kettering Cancer Center, New York, New York.
Cancer ; 124(7): 1374-1382, 2018 04 01.
Article en En | MEDLINE | ID: mdl-29338080
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Mutación de Línea Germinal / Proteína BRCA1 / Carcinoma Ductal Pancreático / Proteína BRCA2 Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Neoplasias Pancreáticas / Adenocarcinoma / Protocolos de Quimioterapia Combinada Antineoplásica / Mutación de Línea Germinal / Proteína BRCA1 / Carcinoma Ductal Pancreático / Proteína BRCA2 Tipo de estudio: Clinical_trials / Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Cancer Año: 2018 Tipo del documento: Article